241 related articles for article (PubMed ID: 16716091)
1. Sildenafil, a PDE5 inhibitor, in the treatment of pulmonary hypertension.
Hemnes AR; Champion HC
Expert Rev Cardiovasc Ther; 2006 May; 4(3):293-300. PubMed ID: 16716091
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Ghofrani HA; Grimminger F
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate therapy for pulmonary arterial hypertension.
Izbicki G; Rosengarten D; Picard E
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528809
[No Abstract] [Full Text] [Related]
4. Sildenafil citrate therapy for pulmonary arterial hypertension.
Kuschner WG
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16528810
[No Abstract] [Full Text] [Related]
5. Sildenafil in pulmonary hypertension.
Nanivadekar A
Indian Heart J; 2003; 55(3):285; author reply 285. PubMed ID: 14560947
[No Abstract] [Full Text] [Related]
6. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
[TBL] [Abstract][Full Text] [Related]
7. Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.
Lewis GD; Semigran MJ
Curr Heart Fail Rep; 2004 Dec; 1(4):183-9. PubMed ID: 16036043
[TBL] [Abstract][Full Text] [Related]
8. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan.
Minai OA; Arroliga AC
South Med J; 2006 Aug; 99(8):880-3. PubMed ID: 16929886
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
Steiner MK; Preston IR; Klinger JR; Hill NS
Curr Opin Pharmacol; 2005 Jun; 5(3):245-50. PubMed ID: 15907910
[TBL] [Abstract][Full Text] [Related]
10. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil in primary pulmonary hypertension.
Prasad S; Wilkinson J; Gatzoulis MA
N Engl J Med; 2000 Nov; 343(18):1342. PubMed ID: 11183578
[No Abstract] [Full Text] [Related]
12. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil in neonatal pulmonary hypertension due to impaired alveolarisation and plexiform pulmonary arteriopathy.
Chaudhari M; Vogel M; Wright C; Smith J; Haworth SG
Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F527-8. PubMed ID: 16244212
[TBL] [Abstract][Full Text] [Related]
14. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
Hoeper MM
Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
[No Abstract] [Full Text] [Related]
15. Sildenafil in the treatment of pulmonary hypertension.
Barnett CF; Machado RF
Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
[TBL] [Abstract][Full Text] [Related]
16. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
17. Signaling molecules in overcirculation-induced pulmonary hypertension in piglets: effects of sildenafil therapy.
Rondelet B; Kerbaul F; Van Beneden R; Motte S; Fesler P; Hubloue I; Remmelink M; Brimioulle S; Salmon I; Ketelslegers JM; Naeije R
Circulation; 2004 Oct; 110(15):2220-5. PubMed ID: 15466636
[TBL] [Abstract][Full Text] [Related]
18. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine.
Lacassie HJ; Germain AM; Valdés G; Fernández MS; Allamand F; López H
Obstet Gynecol; 2004 May; 103(5 Pt 2):1118-20. PubMed ID: 15121629
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate therapy for pulmonary arterial hypertension.
Hoeper MM; Welte T
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16525151
[No Abstract] [Full Text] [Related]
20. Sildenafil citrate therapy for pulmonary arterial hypertension.
Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
